| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Second Regular National Report on the Implementation of the Cartagena Protocol on Biosafety
Record information and status
Record ID
102412
Status
Published
Date of creation
2011-09-30 21:34 UTC (alexmay@sfe.go.cr)
Date of publication
2011-09-30 21:34 UTC (alexmay@sfe.go.cr)

This document is also available in the following languages:
Origin of report
Country
  • Costa Rica
Contact officer for report
Coordinates
INGENIERO ALEX MAY
PUNTO FOCAL NACIONAL PROTOCOLO DE CARTAGENA
MINISTERIO AGRICULTURA Y GANADERIA (MAG )
MINISTERIO DE AGRICULTURA Y GANADERIA, SERVICIO FITOSANITARIO DEL ESTADO SABANA SUR ANTIGUO EDIFICIO DE LA SALLE.
SAN JOSE, COSTA RICA
Costa Rica, 1521-1200 COSTA RICA
Phone:506-2549-3563
Fax:506-2549-3598
Email:alexmay@sfe.go.cr
Consulted stakeholders
9. Organizations/stakeholders who were consulted or participated in the preparation of this report
ES
Industria Biotecnológica (Semillas del Trópico, Delta and Pine Semillas (Monsanto), LM-21, UNIPO S.A., Ministerio de Comercio Exterior (COMEX), Ministerio de Ciencia y Tecnología (MICIT) ; Comisión Técnica Nacional de Bioseguridad (CTNBio), Cámara de Agricultura, Instituto Costarricense de Pesca y Acuicultura (INCOPESCA), Instituto de Investigación e Innovación en Transferencia de Tecnología Agropecuaria (INTA), Universidad de Costa Rica (UCR), Ministerio de Agricultura y Ganadería (MAG), Ministerio de Ambiente, Energía y Telecomunicaciones (MINAET), Ministerio de Salud, Cámara de Industriales de Alimentos Balanceados (CIAB), Ministerio de Economía, Industria y Comercio (MEIC), Servicio Nacional de Salud Animal (SENASA), Cámara Costarricense de Importadores de Graneles (CACIGRA), Industria Nacional de Oleaginosas S.A. (INOLASA), Cámara Nacional de Agricultura y agroindustria (CNAA), Punto operativo de GEF, Cámara Costarricense de la Industria Alimentaria (CACIA), Oficina Asuntos Internacionales de MINAET, Comisión Nacional para la Gestión de la Biodiversidad (CONAGEBio), Instituto Nacional de Biodiversidad (INBIO), Proyecto UNEP/GEF (Implementación de un Marco de Bioseguridad para Costa Rica). Además de la Agencia para Alimentos y Drogas de los Estados Unidos (FDA), como observador.
Submission
10. Date of submission
2011-09-30
11. Time period covered by this report
Start date
2007-09-11
Time period covered by this report
End date
2011-09-30
Party to the Cartagena Protocol on Biosafety
12. Is your country a Party to the Cartagena Protocol on Biosafety (CPB)?
  • Yes
Article 2 – General provisions
15. Has your country introduced the necessary legal, administrative and other measures for the implementation of the Protocol?
  • A domestic regulatory framework is partially in place
16. Which specific instruments are in place for the implementation of your national biosafety framework?
  • One or more national biosafety laws
  • One or more national biosafety regulations
  • One or more sets of biosafety guidelines
17. Has your country established a mechanism for the budgetary allocations of funds for the operation of its national biosafety framework?
  • Yes
18. Does your country have permanent staff to administer functions directly related to the national biosafety framework?
  • Yes
19. If you answered Yes to question 18, how many permanent staff members are in place whose functions are directly related to the national biosafety framework?
  • More than 10
20. Has your country’s biosafety framework / laws / regulations / guidelines been submitted to the Biosafety Clearing-House (BCH)?
  • Yes
21. Here you may provide further details on the implementation of Article 2 in your country:
ES
Dentro de las medidas que se han introducido, actualmente se esta ejecutando un Proyecto UNEP-GEF de Implementación de un Marco Nacional sobre Seguridad de la Biotecnología GLF/2328-2716-4B61 (Duración 36 meses, Octubre 2010 a Octubre 2013), así como el Proyecto LAC Biosafety: América Latina: Construcción de Capacidad multipaís para el cumplimiento del Protocolo de Cartagena en Bioseguridad.
En cumplimiento con los instrumentos jurídicos establecidos hay un conjunto de leyes, las cuáles son: Ley de Protección Fitosanitaria n° 7664 y su reglamento n° 26921-MAG, Ley de Biodiversidad n°7788, Ley SENASA n°8495, Reglamento de Auditores en Bioseguridad n°32486-MAG.

En recurso humano disponible y permanente, en el país existe una participación Interministerial, por medio de la integración de la Comisión Técnica Nacional de Bioseguridad, creada por ley y ratificada su constitución y funciones por la Ley de SENASA y la Ley de Biodiversidad, además de Organizaciones N° Gubernamentales y de empresa privada en las actividades relacionadas en materia de OVM´s, por tanto se contabilizan más de 10 personas en funciones relacionadas con la materia
La Ley de Protección Fitosanitaria Nº 7664, en su articulo 40 crea la Comisión Técnica Nacional de Bioseguridad y en su Reglamento Nº26921 articulo 112 indica su conformación de la siguiente manera:

1. Un representante del Ministerio de Ciencia y Tecnología.

2. Dos representantes del Ministerio de Agricultura y Ganadería.

3. Dos representantes del Ministerio del Ambiente y Energía.

4. Un representante de la Oficina Nacional de Semillas.

5. Dos representantes designados por la Academia Nacional de Ciencias.

6. Un representante de la Federación para la Conservación del Ambiente.

7. Un representante de la Red de Coordinación en Biodiversidad.
Article 5 – Pharmaceuticals
22. Does your country regulate the transboundary movement, handling and use of living modified organisms (LMOs) which are pharmaceuticals?
  • No
24. Here you may provide further details on the implementation of Article 5 in your country:
ES
En el tema de la regulación de OVM´s de uso como productos farmaceúticos en Costa Rica no se regulan estas mercancías. No obstante, El Servicio Nacional de Salud Animal(SENASA), registra únicamente productos de ADN recombinante como lo son las vacunas de uso animal, pero no utilizando los requisitos y parámetros de evaluación de riesgo establecidos en el Protocolo de Cartagena
Article 6 – Transit and Contained use
25. Does your country regulate the transit of LMOs?
  • No
26. Does your country regulate the contained use of LMOs?
  • Yes
27. If you answered Yes to questions 25 or 26, has this information been submitted to the BCH?
  • Partially
28. Here you may provide further details on the implementation of Article 6 in your country:
ES
En materia del uso confinado de OVM´s en Cosa Rica si hay existencia de regulación en materia de OVM's de uso agrícola, como son los articulados de la Ley de Protección Fitosanitaria N° 7664 y su reglamento N° 26921-MAG, Ley de Biodiversidad N°7788, Ley SENASA N°8495, Reglamento de Auditores en Bioseguridad N°32486-MAG.

La información que se debe publicar en el CIISB relativa a tránsito y uso confinado de OVM´s se realiza parcialmente, porque sólo lo relativo a OVM´s de uso agrícola se ha publicado en el CIISB
Articles 7 to 10 – Advance Informed Agreement (AIA) and intentional introduction of LMOs into the environment
29. Has your country adopted law(s) / regulations / administrative measures for the operation of the AIA procedure of the Protocol?
  • No
30. Has your country adopted a domestic regulatory framework consistent with the Protocol regarding the transboundary movement of LMOs for intentional introduction into the environment?
  • No
31. Has your country established a mechanism for taking decisions regarding first intentional transboundary movements of LMOs for intentional introduction into the environment?
  • Yes
32. If you answered Yes to question 31, does the mechanism also apply to cases of intentional introduction of LMOs into the environment that were not subject to transboundary movement?
  • Yes
33. Has your country established a mechanism for monitoring potential effects of LMOs that are released into the environment?
  • Yes
34. Does your country have the capacity to detect and identify LMOs?
  • Yes, to some extent
35. Has your country established legal requirements for exporters under its jurisdiction to notify in writing the competent national authority of the Party of import prior to the intentional transboundary movement of an LMO that falls within the scope of the AIA procedure?
  • Yes
36. Has your country established legal requirements for the accuracy of information contained in the notification?
  • Yes
37. Has your country ever received an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • Yes
38. Has your country ever taken a decision on an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • Yes
39. If you answered Yes to question 38, how many LMOs has your country approved to date for import for intentional introduction into the environment?
  • More than 10
40. If you answered Yes to question 38, how many LMOs, not imported, has your country approved to date for intentional introduction into the environment?
  • Less than 5
41. In the current reporting period, how many applications/notifications has your country received regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • More than 10
42. In the current reporting period, how many decisions has your country taken regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • More than 10
43. With reference to the decisions taken on intentional transboundary movements of LMOs for intentional introduction into the environment, has your country received a notification from the Party(ies) of export or from the exporter(s) prior to the transboundary movement?
  • Yes, always
44. Did the notifications contain complete information (at a minimum the information specified in Annex I of the Cartagena Protocol on Biosafety)?
  • Yes, always
45. Has your country acknowledged receipt of the notifications to the notifier within ninety days of receipt?
  • Yes, always
46. Has your country informed the notifier(s) and the BCH of its decision(s)?
  • Yes, always
47. Has your country informed the notifier(s) and the BCH of its decision(s) in due time (within 270 days or the period specified in your communication to the notifier)?
  • Yes, always
48. What percentage of your country’s decisions fall into the following categories?
  • Approval of the import/use of the LMO(s) with conditions
100%
49. In cases where your country approved an import with conditions or prohibited an import, did it provide reasons on which its decisions were based to the notifier and the BCH?
  • Yes, always
50. Here you may provide further details on the implementation of Articles 7-10 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs for intentional introduction to the environment:
ES
Con relación al procedimiento de acuerdo fundamentado previo e introducción deliberada de OVM´s en el medio ambiente, las respuestas que se consignan en esta sección son respuestas basadas estrictamente en el cumplimiento e implementación del Protocolo de Cartagena (PCSB), sin embargo, la legislación nacional en algunos aspectos es concordante con el PCSB principalmente en materia agrícola, según artículos 117 y 118 del Reglamento a la Ley de Fitoprotección N°26921.
Costa Rica ha desarrollado una estrategia para fortalecer el monitoreo y la vigilancia postliberación y para ello ha diseñado e implementado regulación contenida en el Reglamento en Auditorias en Bioseguridad Agrícola N° 32486-MAG.
En cuanto a las estrategias para la detección de OVM´s, El Servicio Fitosanitario del Estado-Ministerio de Agricultura cuenta con equipo y recurso humano para la detección de OVM´s, pero actualmente ninguna institución pública ni privada está realizando detección de OVM´s
Article 11 – Procedure for living modified organisms intended for direct use as food or feed, or for processing (LMOs-FFP)
51. Has your country adopted specific law(s) or regulation(s) for decision-making regarding domestic use, including placing on the market, of LMOs-FFP?
  • No
52. Has your country established legal requirements for the accuracy of information to be provided by the applicant?
  • No
53. Has your country established a mechanism to ensure that decisions regarding LMOs-FFP that may be subject to transboundary movement will be communicated to the Parties through the BCH?
  • No
54. Has your country established a mechanism for taking decisions on the import of LMOs-FFP?
  • No
55. Has your country declared through the BCH that in the absence of a regulatory framework its decisions prior to the first import of an LMO-FFP will be taken according to Article 11.6 of the Cartagena Protocol on Biosafety?
  • No
56. Has your country indicated its needs for financial and technical assistance and capacity building in respect of LMOs-FFP?
  • Yes
57. Has your country ever taken a decision on LMOs-FFP (either on import or domestic use)?
  • No
63. Here you may provide further details on the implementation of Article 11 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs-FFP:
ES
En estos momentos existe una Ley (Protocolo de Cartagena), pero no se ha implementado su artículo 11. Costa Rica no ha desarrollado normativas, procedimientos o cualquier otro mecanismo para su implementación. Sin embargo, El Proyecto UNEP-GEF(Implementación de un Marco de Bioseguridad para Costa Rica), en el ámbito de sus actividades tiene acciones para establecer mecanismos de coordinación en el área legal, técnica y administrativa para implementar el artículo 11 de la Ley Nacional N°8537. Dentro de las actividades de creación de capacidades se va a solicitar colaboración a agencias regulatorias internacionales para entrenar personal de las Autoridades Nacionales Competentes y demás instituciones relacionadas con la aplicación de este artículo
Article 12 – Review of decision
64. Has your country established a mechanism for the review and change of a decision regarding an intentional transboundary movement of LMOs?
  • Yes
65. Has your country ever received a request for a review of a decision?
  • Yes
66. Has your country ever reviewed / changed a decision regarding an intentional transboundary movement of LMOs?
  • Yes, decision reviewed
67. In the current reporting period, how many decisions were reviewed and/or changed regarding an intentional transboundary movement of an LMO?
  • Less than 5
68. Has your country informed the notifier and the BCH of the review and/or changes in the decision?
  • In some cases only the BCH
69. Has your country informed the notifier and the BCH of the review and changes in the decision within thirty days?
  • In some cases only
70. Has your country provided reasons to the notifier and the BCH for the review and/or changes in the decision?
  • In some cases only
71. Here you may provide further details on the implementation of Article 12 in your country:
ES
En cumplimiento a este artículo del Protocolo sobre la revisión de las decisiones tomadas, al momento no ha habido una revisión de una decisión que amerite ser publicada en el CIISB.
Article 13 – Simplified procedure
72. Has your country established a system for the application of the simplified procedure regarding an intentional transboundary movement of LMOs?
  • No
73. Has your country ever applied the simplified procedure?
  • No
75. In the current reporting period, how many LMOs has your country applied the simplified procedure to?
  • None
76. Here you may provide further details on the implementation of Article 13 in your country:
ES
Costa Rica no ha tomado acuerdo sobre la utilización de un mecanismo de acuerdo de procedimiento simplificado, sin embargo, el mecanismo se encuentra en estudio en el ámbito de la Comisión Técnica Nacional de Bioseguridad (CTNBio)
Article 14 – Bilateral, regional and multilateral agreements and arrangements
77. Has your country entered into any bilateral, regional or multilateral agreements or arrangements?
  • No
80. Here you may provide further details on the implementation of Article 14 in your country:
ES
Actualmente Costa Rica no tiene acuerdos bilaterales o multilaterales, sin embargo, en el ámbito de las actividades del Proyecto UNEP/GEF(Implementación de un Marco de Bioseguridad para Costa Rica), se encuentra en proceso de facilitación de una negociación de acuerdos bilaterales y multilaterales entre estados parte y no parte con los cuales Costa Rica es socio comercial y realiza movimientos transfronterizos de OVM`s
Article 15 – Risk assessment
81. Has your country established a mechanism for conducting risk assessments prior to taking decisions regarding LMOs?
  • No
83. Has your country established guidelines for how to conduct risk assessments prior to taking decisions regarding LMOs?
  • No
84. Has your country acquired the necessary domestic capacity to conduct risk assessment?
  • Yes
85. Has your country established a mechanism for training national experts to conduct risk assessments?
  • No
86. Has your country ever conducted a risk assessment of an LMO for intentional introduction into the environment?
  • No
87. Has your country ever conducted a risk assessment of an LMO intended for direct use as food or feed, or for processing?
  • No
88. If your country has taken decision(s) on LMOs for intentional introduction into the environment or on domestic use of LMOs-FFP, were risk assessments conducted for all decisions taken?
  • No
89. Has your country submitted summary reports of the risk assessments to the BCH?
  • Yes, always
90. In the current reporting period, if your country has taken decisions regarding LMOs, how many risk assessments were conducted in the context of these decisions?
  • None
91. Has your country ever required the exporter to conduct the risk assessment(s)?
  • In some cases only
92. Has your country ever required the notifier to bear the cost of the risk assessment(s) of LMOs?
  • Yes, always
93. Here you may provide further details on the implementation of Article 15 in your country:
ES
Las evaluaciones de riesgos que se realizan en Costa Rica en cumplimiento de la Legislación Nacional son para las liberaciones al ambiente, para uso confinado y experimental de uso agrícola, y el mecanismo utilizado en el país es que la Comisión Técnica Nacional de Bioseguridad analiza las evaluaciones del riesgo presentadas por el interesado, en concordancia con los anexos I y III del Protocolo de Cartagena el cual se toma como base para generar un dictamen técnico, correspondiente a lo establecido en La Ley de Protección Fitosanitaria N° 7664 y su reglamento N°26921 en sus artículos del 111 al 134
Article 16 – Risk management
94. Has your country established and maintained appropriate and operational mechanisms, measures and strategies to regulate, manage and control risks identified in risk assessments for:
94.1) LMOs for intentional introduction into the environment?
  • Yes
94.2) LMOs intended for direct use as food or feed, or for processing?
  • No
95. Has your country established and maintained appropriate measures to prevent unintentional transboundary movements of LMOs?
  • Yes, to some extent
96. Has your country taken measures to ensure that any LMO, whether imported or locally developed, undergoes an appropriate period of observation that is commensurate with its life-cycle or generation time before it is put to its intended use?
  • No
97. Has your country cooperated with other Parties with a view to identifying LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
  • No
98. Has your country cooperated with other Parties with a view to taking measures regarding the treatment of LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
  • No
99. Here you may provide further details on the implementation of Article 16 in your country, including any details regarding risk management strategies, also in case of lack of scientific certainty on potential adverse effects of LMOs:
ES
La gestión del riesgo es una de las principales herramientas que se utiliza para monitorear que las medidas establecidas por las Autoridades Nacionales Competentes efectivamente minimicen el posible riesgo valorado. Particularmente la CTNBio establece y comunica en el Certificado de Liberación al Ambiente las medidas que se deben tomar para administrar el riesgo
Article 17 – Unintentional transboundary movements and emergency measures
100. Has your country made available to the BCH the relevant details setting out its point of contact for the purposes of receiving notifications under Article 17?
  • Yes
101. Has your country established a mechanism for addressing emergency measures in case of unintentional transboundary movements of LMOs that are likely to have significant adverse effect on biological diversity?
  • Yes
102. Has your country implemented emergency measures in response to information about releases that led, or may have led, to unintentional transboundary movements of LMOs?
  • Yes
103. In the current reporting period, how many times has your country received information concerning occurrences that led, or may have led, to unintentional transboundary movement(s) of one or more LMOs to or from territories under its jurisdiction?
  • Never
107. Here you may provide further details on the implementation of Article 17 in your country:
ES
Costa Rica ha comunicado a la Secretaría del CBD, la designación del Punto de Contacto de Emergencia. Costa Rica ha desarrollado legislación contenida dentro de La ley de Biodiversidad N° 7788 Art. 48 y el Reglamento a la ley de Protección Fitosanitaria Nº 26921, lo que le da respaldo jurídico a las medidas de emergencia en caso del movimiento
transfronterizos involuntarios de OVM´s
Article 18 – Handling, transport, packaging and identification
108. Has your country taken measures to require that LMOs that are subject to transboundary movement are handled, packaged and transported under conditions of safety, taking into account relevant international rules and standards?
  • No
109. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is not known through means such as identity preservation systems, they may contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
  • No
110. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is known through means such as identity preservation systems, they contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
  • No
111. Has your country taken measures to require that documentation accompanying LMOs that are destined for contained use clearly identifies them as living modified organisms and specifies any requirements for the safe handling, storage, transport and use, the contact point for further information, including the name and address of the individual and institution to whom the LMO are consigned?
  • Yes
112. Has your country taken measures to require that documentation accompanying LMOs that are intended for intentional introduction into the environment of the Party of import, clearly identifies them as living modified organisms; specifies the identity and relevant traits and/or characteristics, any requirements for the safe handling, storage, transport and use, the contact point for further information and, as appropriate, the name and address of the importer and exporter; and contains a declaration that the movement is in conformity with the requirements of this Protocol applicable to the exporter?
  • Yes, to some extent
113. Does your country have the capacity to enforce the requirements of identification and documentation of LMOs?
  • Yes, to some extent
114. Has your country established procedures for the sampling and detection of LMOs?
  • No
115. Here you may provide further details on the implementation of Article 18 in your country:
ES
A nivel nacional se han establecido guías, protocolos y procedimientos denominados BIOs, para el etiquetado, el transporte, la movilización, la identificación y la comercialización de OVM´s para uso agrícola, pero no para OVM´s para consumo humano, animal y procesamiento, los cuales se indican en los artículos 117, 118, 121, 122, 127, 128, 129, 131, entre otros, del reglamento a la Ley de Protección Fitosanitaria N° 7664
Article 19 – Competent National Authorities and National Focal Points
116. Has your country designated one national focal point for the Cartagena Protocol to be responsible for liaison with the Secretariat?
  • Yes
117. Has your country designated one national focal point for the Biosafety Clearing-House to liaise with the Secretariat regarding issues of relevance to the development and implementation of the BCH?
  • Yes
118. Has your country designated one or more competent national authorities, which are responsible for performing the administrative functions required by the Cartagena Protocol on Biosafety and are authorized to act on your country’s behalf with respect to those functions?
  • Yes, more than one
119. In case your country designated more than one competent national authority, has your country conveyed to the Secretariat the respective responsibilities of those authorities?
  • Yes
120. Has your country made available the required information referred in questions 116-119 to the BCH?
  • Yes, all information
121. In case your country has designated more than one competent national authority, has your country established a mechanism for the coordination of their actions prior to taking decisions regarding LMOs?
  • Yes
122. Has your country established adequate institutional capacity to enable the competent national authority(ies) to perform the administrative functions required by the Cartagena Protocol on Biosafety?
  • Yes
123. Here you may provide further details on the implementation of Article 19 in your country:
ES
Costa Rica ha comunicado la designación de un Punto Focal del Protocolo de
Cartagena y el CIISB; asimismo, se ha designado e informado al CIISB las Autoridades Nacionales Competentes y ha establecido mediante la creación de la Comisión Técnica Nacional de Bioseguridad mecanismos y procedimientos para antes y a la hora de tomar decisiones. Establecido en la Ley de Protección Fitosanitaria Nº 7664, en su articulo 40 crea la Comisión Técnica Nacional de Bioseguridad y en su Reglamento Nº26921 artículo 112 indica su conformación de la siguiente manera:

1. Un representante del Ministerio de Ciencia y Tecnología.

2. Dos representantes del Ministerio de Agricultura y Ganadería.

3. Dos representantes del Ministerio del Ambiente y Energía.

4. Un representante de la Oficina Nacional de Semillas.

5. Dos representantes designados por la Academia Nacional de Ciencias.

6. Un representante de la Federación para la Conservación del Ambiente.

7. Un representante de la Red de Coordinación en Biodiversidad; y otros artículos tales como: 113,114 y 115
Article 20 – Information Sharing and the Biosafety Clearing-House (BCH)
124. Please provide an overview of the status of the information provided by your country to the BCH by specifying for each category of information whether it is available and whether it has been submitted to the BCH.
124.a) Existing national legislation, regulations and guidelines for implementing the Protocol, as well as information required by Parties for the advance informed agreement procedure (Article 20, paragraph 3 (a))
  • Information available and in the BCH
124.b) National laws, regulations and guidelines applicable to the import of LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 5)
  • Information not available
124.c) Bilateral, multilateral and regional agreements and arrangements (Articles 14, paragraph 2 and 20, paragraph 3 (b))
  • Information not available
124.d) Contact details for competent national authorities (Article 19, paragraphs 2 and 3), national focal points (Article 19, paragraphs 1 and 3), and emergency contacts (Article 17, paragraph 3 (e))
  • Information available and in the BCH
124.e) Reports submitted by the Parties on the operation of the Protocol (Article 20, paragraph 3 (e))
  • Information available and in the BCH
124.f) Decisions by a Party on regulating the transit of specific living modified organisms (LMOs) (Article 6, paragraph 1)
  • Information not available
124.g) Occurrence of unintentional transboundary movements that are likely to have significant adverse effects on biological diversity (Article 17, paragraph 1)
  • Information not available
124.h) Illegal transboundary movements of LMOs (Article 25, paragraph 3)
  • Information not available
124.i) Final decisions regarding the importation or release of LMOs (i.e. approval or prohibition, any conditions, requests for further information, extensions granted, reasons for decision) (Articles 10, paragraph 3 and 20, paragraph 3(d))
  • Information available and in the BCH
124.j) Information on the application of domestic regulations to specific imports of LMOs (Article 14, paragraph 4)
  • Information available and in the BCH
124.k) Final decisions regarding the domestic use of LMOs that may be subject to transboundary movement for direct use as food or feed, or for processing (Article 11, paragraph 1)
  • Information not available
124.l) Final decisions regarding the import of LMOs intended for direct use as food or feed, or for processing that are taken under domestic regulatory frameworks (Article 11, paragraph 4) or in accordance with annex III (Article 11, paragraph 6) (requirement of Article 20, paragraph 3(d))
  • Information not available
124.m) Declarations regarding the framework to be used for LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 6)
  • Information not available
124.n) Review and change of decisions regarding intentional transboundary movements of LMOs (Article 12, paragraph 1)
  • Information not available
124.o) LMOs granted exemption status by each Party (Article 13, paragraph 1)
  • Information not available
124.p) Cases where intentional transboundary movement may take place at the same time as the movement is notified to the Party of import (Article 13, paragraph 1)
  • Information not available
124.q) Summaries of risk assessments or environmental reviews of LMOs generated by regulatory processes and relevant information regarding products thereof (Article 20, paragraph 3 (c))
  • Information available and in the BCH
125. Has your country established a mechanism for strengthening the capacity of the BCH National Focal Point to perform its administrative functions?
  • No
126. Has your country established a mechanism for the coordination among the BCH National Focal Point, the Cartagena Protocol focal point, and the competent national authority(ies) for making information available to the BCH?
  • Yes
127. Does your country use the information available in the BCH in its decision making processes on LMOs?
  • Yes, always
128. Has your country experienced difficulties accessing or using the BCH?
  • No
129. If you answered Yes to question 128, has your country reported these problems to the BCH or the Secretariat?
  • Not applicable
130. Is the information submitted by your country to the BCH complete and up-to date?
  • No
131. Here you may provide further details on the implementation of Article 20 in your country:
ES
El CIISB se encuentra actualizado en materia de OVM´s de uso agrícola. El CIISB para Costa Rica tiene un grupo de trabajo integrado por representantes de Servicio Nacional de Salud Animal, Servicio Fitosanitario del Estado, Ministerio de salud y Ministerio de Ambiente, Energía y Telecomunicaciones. En estos momentos el país está participando en el CIISB II, para promover la creación de capacidades entre las Autoridades Nacionales Competentes y otros interesados. Costa Rica  cuenta  con  una pagina o aplicacion  nacional  basado en las  herramientas  Hermes y Ajax. 
Article 21 – Confidential information
132. Has your country established procedures to protect confidential information received under the Protocol?
  • Yes
133. Does your country allow the notifier to identify information that is to be treated as confidential?
  • Yes, always
134. Here you may provide further details on the implementation of Article 21 in your country:
ES
Dentro de la legislación Nacional la información confidencial está regulada por la Ley Nacional N°7975 (Ley de Información no divulgada)
Article 22 – Capacity-building
135. Has your country received external support or benefited from collaborative activities with other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
136. If you answered Yes to question 135, how were these resources made available?
  • Regional channels
137. Has your country provided support to other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
138. If you answered Yes to question 137, how were these resources made available?
  • Regional channels
139. Is your country eligible to receive funding from the Global Environment Facility (GEF)?
  • Yes
140. Has your country ever initiated a process to access GEF funds for building capacity in biosafety?
  • Yes
141. If you answered Yes to question 140, how would you characterize the process?
Please add further details about your experience in accessing GEF funds under question 150.
  • Difficult
142. Has your country ever received funding from the GEF for building capacity in biosafety?
  • Pilot Biosafety Enabling Activity
  • Development of national biosafety frameworks
  • Implementation of national biosafety frameworks
  • Building Capacity for Effective Participation in the BCH (Phase I)
  • Building Capacity for Effective Participation in the BCH (Phase II)
143. During the current reporting period, has your country undertaken activities for the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
144. If you answered Yes to question 143, in which of the following areas were these activities undertaken?
  • Institutional capacity
  • Human resources capacity development and training
  • Risk assessment and other scientific and technical expertise
  • Risk management
  • Public awareness, participation and education in biosafety
  • Information exchange and data management including participation in the Biosafety Clearing-House
  • Scientific, technical and institutional collaboration at subregional, regional and international levels
  • Technology transfer
145. During the current reporting period, has your country carried out a capacity-building needs assessment?
  • Yes
146. Does your country still have capacity-building needs?
  • Yes
147. If you answered Yes to question 146, indicate which of the following areas still need capacity-building.
  • Institutional capacity
  • Human resources capacity development and training
  • Risk assessment and other scientific and technical expertise
  • Risk management
  • Public awareness, participation and education in biosafety
  • Information exchange and data management including participation in the Biosafety Clearing-House
  • Scientific, technical and institutional collaboration at subregional, regional and international levels
  • Technology transfer
  • Identification of LMOs, including their detection
  • Socio-economic considerations
  • Implementation of the documentation requirements under Article 18.2 of the Protocol
  • Handling of confidential information
  • Measures to address unintentional and/or illegal transboundary movements of LMOs
  • Scientific biosafety research relating to LMOs
  • Taking into account risks to human health
148. Has your country developed a capacity-building strategy or action plan?
  • Yes
149. Has your country submitted the details of national biosafety experts to the Roster of Experts in the BCH?
  • Yes
150. Here you may provide further details on the implementation of Article 22 in your country, including further details about your experience in accessing GEF funds:
ES
Si se ha obtenido financiamiento, aunque el proceso para obtener fondos del FMAM para la creación de capacidad relativa a la seguridad de la Biotecnología es complejo para el país solicitante. El área de Salud Humana y Animal no han recibido capacitación en la evaluación y gestión de riesgos. El Proyecto de Implementación de un Marco Nacional de Bioseguridad N° GLF/2328-2716-4B61, contempla un plan de acción para creación de capacidad en áreas prioritarias.
Article 23 – Public awareness and participation
151. Has your country established a strategy or put in place legislation for promoting and facilitating public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • Yes, to some extent
152. Has your country established a biosafety website?
  • Yes
153. Has your country established a mechanism to ensure public access to information on living modified organisms that may be imported?
  • Yes
154. Has your country established a mechanism to consult the public in the decision-making process regarding LMOs?
  • Yes
155. Has your country established a mechanism to make available to the public the results of decisions taken on LMOs?
  • Yes
156. Has your country taken any initiative to inform its public about the means of public access to the Biosafety Clearing-House?
  • Yes
157. In the current reporting period, has your country promoted and facilitated public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • Yes, to a limited extent
158. If you answered Yes to question 157, has your country cooperated with other States and international bodies?
  • Not applicable
159. In the current reporting period, how many times has your country consulted the public in the decision-making process regarding LMOs and made the results of such decisions available to the public?
  • More than 5
160. Here you may provide further details on the implementation of Article 23 in your country:
ES
No existe una estrategia de concientización y participación del público, pero Costa Rica ha implementado mecanismos para la consulta al público en el proceso de adopción de decisiones, los cuáles están tipificados en el Reglamento de la Ley de Protección Fitosanitaria Nº 26921 articulo 133, asimismo el Reglamento del Capitulo III de la Ley de Biodiversidad incluye un mecanismo.

El Proyecto de Implementación de un Marco Nacional de Bioseguridad N° GLF/2328-2716-4B61, contempla un componente dirigido a la concienciación y participación del público, así como el Proyecto LAC Biosafety(Construcción de capacidad multipaís para el Protocolo de Cartagena sobre Bioseguridad), financiado por el GEF y administrado por el Banco Mundial, también en ejecución, tiene un componente en esta materia, el cuál promoverá una mayor participación de la sociedad civil
Article 24 – Non-Parties
161. Has your country entered into any bilateral, regional, or multilateral agreement with non-Parties regarding transboundary movements of LMOs?
  • No
162. Has your country ever imported LMOs from a non-Party?
  • Yes
163. Has your country ever exported LMOs to a non-Party?
  • Yes
164. If you answered Yes to questions 162 or 163, were the transboundary movements of LMOs consistent with the objective of the Cartagena Protocol on Biosafety?
  • In some cases only
165. If you answered Yes to questions 162 or 163, was information about these transboundary movements submitted to the BCH?
  • In some cases only
166. If your country is not a Party to the Cartagena Protocol, has it contributed information to the BCH on LMOs released in, or moved into, or out of, areas within its national jurisdiction?
  • Not applicable
167. Here you may provide further details on the implementation of Article 24 in your country:
ES
Actualmente, la principal actividad en Costa Rica de OVM´s es la investigación y el incremento de semilla que son exportadas a un Estado que no es parte. Asimismo, los movimientos transfronterizos principales que vienen a Costa Rica se importan de un Estado no parte. Sin embargo, se realizan ambos movimientos transfronterizos en concordancia con los procedimientos generales establecidos en el Protocolo Cartagena y la leyes nacionales vigentes
Article 25 – Illegal transboundary movements
168. Has your country adopted domestic measures aimed at preventing and/or penalizing transboundary movements of LMOs carried out in contravention of its domestic measures to implement this Protocol?
  • Yes
169. Has your country established a strategy for detecting illegal transboundary movements of LMOs?
  • No
170. In the current reporting period, how many times has your country received information concerning cases of illegal transboundary movements of an LMO to or from territories under its jurisdiction?
  • Never
175. Here you may provide further details on the implementation of Article 25 in your country:
ES
Costa Rica no ha recibido comunicación sobre movimientos transfronterizos ilícitos por conducto del CIISB, ni por ningún otro mecanismo nacional o regional existente
Article 26 – Socio-economic considerations
176. If your country has taken a decision on import, has it ever taken into account socio-economic considerations arising from the impact of the LMO on the conservation and sustainable use of biological diversity?
  • No
177. Has your country cooperated with other Parties on research and information exchange on any socio-economic impacts of LMOs?
  • No
178. Here you may provide further details on the implementation of Article 26 in your country:
ES
La Comisión Técnica Nacional de Bioseguridad emite recomendaciones basándose en criterios tecnico-científicos
Article 27 – Liability and Redress
179. Has your country signed the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress?
  • No
180. Has your country initiated steps towards ratification, acceptance or approval of the Nagoya-Kuala Lumpur Supplementary Protocol?
  • No
181. Here you may provide further details on any activities undertaken in your country towards the implementation of the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress:
ES
Costa Rica no ha emprendido ninguna acción con respecto de este Protocolo.
Article 33 – Monitoring and reporting
182. Has your country submitted the previous national reports (Interim and First National Reports)?
  • Yes, First report only
Other information
184. Please use this field to provide any other information on issues related to national implementation of the Protocol, including any obstacles or impediments encountered.
ES
Los diagnósticos que se han realizado para conocer el grado de avance y cumplimiento de Costa Rica en la implementación del Protocolo de Cartagena, muestran deficiencias en el ámbito jurídico, administrativo, de recurso humano, de educación y concienciación en el tema de alimentos y otros OVM´s no convencionales, tales como: árboles, peces, insectos, microorganismos, entre otros. Así mismo, los informes han demostrado que cualquier generación de nuevos procedimientos, requisitos, entre otros, deben considerar que el exceso de trámites o la ausencia de procedimientos obstaculiza el desarrollo de la tecnología y por lo tanto la implementación del Protocolo de Cartagena.
Es necesario el desarrollo de capacidades en diferentes niveles, tales como: tomadores de decisiones, comunicadores, técnico-científicos sobre la implementación del Protocolo de Cartagena.
Comments on reporting format
185. Please use this field to provide any other information on difficulties that you have encountered in filling in this report.
ES
En algunos casos la redacción de las preguntas dan lugar a diferentes interpretaciones, por consiguiente fue difícil brindar una respuesta concreta, por lo que fue necesario la utilización de los espacios al final de cada artículo, para aclarar el contenido de cada uno y particularmente en las preguntas relacionadas con la aplicación de la legislación nacional y el Protocolo de Cartagena.
Survey on indicators of the Strategic Plan (2014)
In decision BS-VI/15, Parties requested the Executive Secretary to conduct a dedicated survey to gather information corresponding to indicators in the Strategic Plan that could not be obtained from the second national reports or through other existing mechanisms.

The answers to the survey are displayed below.
When did your national biosafety framework become operational?
indicator 1.1.1
  • 2001 or earlier
Here you may provide further details
ES
The  national competent autorities  have a national  budget   to  attend and  support  implementation of  the  national  legislation on biosafety each year
Survey 4. How many biosafety short-term training programmes and/or academic courses are offered annually in your country?
indicator 1.2.3
  • 1 per year or more
Here you may provide further details
ES
Training  in risk assesment, global position  system, monitoring,  Cartagena protocol, Nagoya- Kuala lumpur  protocol, etc
Survey 5. Does your country have in place a functional national mechanism for coordinating biosafety capacity-building initiatives?
indicator 1.2.4
  • Yes
Here you may provide further details
ES
We  have  in  Costa Rica  a National Technical Commission  on  Biosafety integrated  by  Ministerio  de  Agricultura y Ganaderia, Ministerio  de  Salud , Ministerio de  Ciencia y Tecnologia, Ministerio de Ambiente  y Energia  for the  coordination   on  capacity- building  activities
Survey 6. How much additional funding (in the equivalent of US dollars) has your country mobilized in the last four years to support implementation of the Biosafety Protocol, beyond the regular national budgetary allocation?
indicator 1.2.5
  • 1,000,000 USD or more
Survey 7. Does your country have predictable and reliable funding for building capacity for the effective implementation of the Protocol?
indicator 1.2.6
  • Yes
Here you may provide further details
ES
The  national competent autorities  have   a national  budget   to  attend   and  support  implementation of  the  national  legislation on biosafety each year
Survey 8. How many LMO-related collaborative bilateral/multilateral arrangements has your country established with other Parties/non-Parties?
indicator 1.2.8
  • None
Survey 9. Has your country adopted or used any guidance documents for the purpose of conducting risk assessment and/or risk management?
indicator 1.3.1.1
Survey 9.a) Risk assessment
  • Yes
Survey 9.b) Risk management
  • Yes
Here you may provide further details
ES
We  have a  national  decree   (Reglamento  a  la  Ley  de Protección Fitosanitaria   Número 26971   de  1998. link: http://bch.cbd.int/database/record.shtml?documentid=39336),   for  risk  assessmentand, risk management  and  a guidelines (Bio-02)
Survey 10. Has your country adopted or used any guidance documents for the purpose of evaluating risk assessment reports submitted by notifiers?
indicator 1.3.1.2
  • No
Survey 11. Has your country adopted any common approaches to risk assessment with other countries?
indicator 1.3.2
  • No
Survey 12. Has your country ever conducted a risk assessment of an LMO?
indicator 1.3.3
  • Yes
Here you may provide further details
ES
Since  1991,  we  are  involved  in activities for  risk  assessment  and  risk management of  LMO, however, in 1997 we have a official legislation on biosafety
Survey 13. Does your country have the capacity to identify, assess and/or monitor living modified organisms or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity, taking into account risks to human health?
indicator 1.4.2
Survey 13.a) Identify
  • Yes
Survey 13.b) Assess
  • Yes
Survey 13.c) Monitor
  • Yes
Here you may provide further details
ES
We have the ability to identify, assess and monitor LMO and its effects on biodiversity, but not in human health
Survey 14. Does your country have available any guidance for the purpose of ensuring the safe handling, transport, and packaging of living modified organisms?
indicator 1.6.4
  • Yes
Here you may provide further details
ES
We  have a  national  decree (Reglamento  a  la  Ley  de Protección Fitosanitaria, Número 26971   de  1998),   for  risk assessmentand, risk management  and  a guidelines for  these activities and Bio-02 guideline.
Survey 15. Does your country have any specific approaches or requirements that facilitate how socio-economic considerations should be taken into account in LMO decision making?
indicator 1.7.2
  • No
Survey 16. How many peer-reviewed published materials has your country used for the purpose of elaborating or determining national actions with regard to socio-economic considerations?
indicator 1.7.1
  • None
Survey 17. What is your country's experience, if any, in taking socio-economic considerations into account in LMO decision making?
indicator 1.7.3
ES
None, The  national  legislation  doesnt have   socio-economic considerations
Survey 18. Does your country have the capacity to take appropriate measures in the event that an LMO is unintentionally released?
indicator 1.8.3
  • Yes
Here you may provide further details
ES
In the  functions  of  the   National Technical Commission of  Biosafety,  we have  guidelines and  agrees (Reglamento  de Auditorias  en Bioseguridad Agrícola  Decreto N 32496-MAG, link: ) for  monitoring,  audits   on LMO
Survey 19. How many people in your country have been trained in risk assessment, monitoring, management and control of LMOs?
indicator 2.2.3
Survey 19.a) Risk assessment
  • 10 or more
Survey 19.b) Monitoring
  • 10 or more
Survey 19.c) Management / Control
  • 10 or more
Here you may provide further details
ES
There have been several national and international courses on the Risk evaluation, monitoring and surveillance.  Courses conducted by the UNEP/GEF Project, IICA, LAC-Biosafety Project
Survey 20. Does your country have the infrastructure (e.g. laboratory facilities) for monitoring or managing LMOs?
indicator 2.2.4
  • No
Survey 21. Is your country using training material and/or technical guidance for training in risk assessment and risk management of LMOs?
indicator 2.2.5
  • Yes
Here you may provide further details
ES
We  have a  national  decree   (  reglamento  a  la  Ley  de Proteccion Fitosanitaria   Numero 26971   de  1978),   for  risk  assessmentand risk management  and  a guidelines for  training including technical documents related biosecurity proposed by UNEP/GEF project
Survey 22. Are the available training materials and technical guidance on risk assessment and risk management of LMOs sufficient and effective?
indicator 2.2.6
Survey 22.a) Sufficient
  • Yes
Survey 22.b) Effective
  • Yes
Here you may provide further details
ES
We have enough training materials and technical guidance on risk assessment and risk management in agricultural activities but not in human health
Survey 23. How many customs officers in your country have received training in the identification of LMOs?
indicator 2.3.1
  • One or more
Here you may provide further details
ES
BCH workshops  trained customs officials
Survey 24. How many laboratory personnel in your country have received training in detection of LMOs?
indicator 2.3.1
  • None
Survey 25. Does your country have reliable access to laboratory facilities for the detection of LMOs?
indicator 2.3.2
  • Yes
Here you may provide further details
ES
We have laboratories with facilities for detection of LMO but these lab doesn't work in detection of LMO`s rigth now
Survey 26. How many laboratories in your country are certified for LMO detection?
indicator 2.3.3
  • None
Survey 27. How many of the certified laboratories in the previous question are operational?
indicator 2.3.4
  • None
Survey 28. Has your country received any financial and/or technical assistance for capacity-building in the area of liability and redress relating to living modified organisms?
indicator 2.4.1
  • No
Survey 29. Does your country have administrative or legal instrument that provide for response measures for damage to biodiversity resulting from living modified organisms?
indicator 2.4.2
  • Yes
Here you may provide further details
ES
We have enough legislation on this issues, Ley de Biodiversidad N 7788 (Link: http://bch.cbd.int/database/record.shtml?documentid=30742), Ley Orgánica del Ambiente, Ley de Proteccion Fitosanitaria N 7664, Ley General de Salud Animal N 8495, etc
Survey 30. Has your country informed the public about existing modalities for public participation in the decision-making process regarding living modified organisms?
indicator 2.5.2
  • Yes
Here you may provide further details
ES
We  have a  national  decree (Reglamento  a  la  Ley  de Protección Fitosanitaria, Número 26971   de  1998),   for  public participation (Bio-02 guideline) and Cartagena Protocol (Art. 20)
Survey 31. If you answered yes to the previous question, please indicate the modalities used to inform the public?
indicator 2.5.2
  • National website
  • Newspaper
Here you may provide further details
ES
We  have a  national  decree (Art. 133, Reglamento  a  la  Ley  de Protección Fitosanitaria, Número 26971   de  1998)
Survey 33. How many academic institutions in your country are offering biosafety education and training courses and programmes?
indicator 2.7.1
  • One or more
Here you may provide further details
ES
Instituto Tecnológico de Costa Rica is offering agricultural biosafety education course
Survey 34. How many biosafety training materials and/or online modules are available in your country?
indicator 2.7.2
  • None
Survey 35. Does your country have in place a monitoring and/or an enforcement system?
indicator 3.1.6
Survey 35.a) Monitoring system
  • Yes
Survey 35.b) Enforcement system
  • Yes
Here you may provide further details
ES
In 2013, was created a Sistema digital para el manejo de información de Organismos Vivos modificados (link: http://www.ovm.go.cr)
Survey 36. Please indicate the number of regional, national and international events organized in relation to biosafety (e.g. seminars, workshops, press conferences, educational events, etc.,) in the last 2 years.
indicator 4.3.1
  • 10 or more
Here you may provide further details
ES
There have been several national and international courses on biosafety. Courses conducted by the UNEP/GEF Project, IICA, LAC-Biosafety Project
Survey 37. Please indicate the number of biosafety related publications that has been made available in your country in the last year.
indicator 4.3.2
  • 10 or more
Here you may provide further details
ES
Publication related of biosafety in the last year like Compendio de Legislación, Introduccion a la Biotecnologia, Plantas Transgenicas, Guia de animales , arboles y artropodos,  Politica y estrategia en Biotecnología y bioseguridad, Convivencia entre cultivos con diferentes técnicas de producción agrícola, Estrategia de educacion en Biotecnologia y Bioseguridad,  relamento   para la autorizacion de   los organismos  geneticamente  modificados   de origen vegetal destinados   para uso directo  como alimento humano o animal o para  procesamiento de alimentos, etc.
Survey 38. If biosafety related publications were made available (see question above), please indicate which modalities were preferred.
indicator 4.3.2
  • The publication related of biosafety were made available for the distribution by national competent authorities to the stakeholders
Survey 39. How many collaborative initiatives (including joint activities) on the Cartagena Protocol and other Conventions and processes has your government established in the last 4 years?
indicator 5.2.1
  • One or more
Here you may provide further details
ES
UNEP-GEF Project, LAC-Biosafety Project, BCH II Project
Survey 40. Does your country have any awareness and outreach programmes on biosafety?
indicator 5.3.1
  • No
Survey 42. Has your country designed and/or implemented an outreach/communication strategy on biosafety?
indicator 5.3.2
  • Yes
Here you may provide further details
ES
Estrategia de Educación en Biotecnología y Bioseguridad para primero y segundo ciclo
Survey 43. Please indicate the number of educational materials on biosafety that are available and accessible to the public.
indicator 5.3.4
  • None
Here you may provide further details
ES
This Estrategia of Educación en Biotecnología y Bioseguridad para primero y segundo ciclo is a proposed in accordance with the National Education System for implement in the  next  year